Abarca Prize

🎉 We are pleased to announce Dr. Juan Luis Arsuaga as a member of the jury for the IV edition of the prestigious Abarca Prize! Doctor in Biological Sciences and professor of Paleontology at the Faculty of Geological Sciences (Universidad Complutense de Madrid), he directs the Joint UCM-Carlos III Institute of Health Center for Human Evolution and Behavior, is co-director of the Atapuerca Sierra sites and the excavations of the Valley of the Neanderthals in Madrid. 🌐 More info: https://lnkd.in/dDrz99pa #AbarcaPrize2024 #researcher #paleontology

💉 Artemisinin, an antimalarial drug, may help treat polycystic ovary syndrome (PCOS). In a recent study in the journal Science, researchers reported that the drug reduced ovarian cysts and normalized menstruation in women with PCOS. These results suggest that artemisinin may offer a new therapeutic approach for this endocrine disorder suffered by hundreds of millions of people around the world. 📚 More information at Science News Magazine: https://ow.ly/7cNI50SQXr5 #antimalarialdrug #PCOS #medicaladvances #research #study #artemisinin

🎉 Dr. Philippe J. Sansonetti, a leader in the field of microbiology, joins the jury for the esteemed Abarca Prize IV edition! Winner of the II Edition of the Abarca Prize, he is a pioneer in cellular microbiology, especially known for his research on shigellosis. Thanks to his groundbreaking research, he has contributed significantly to the understanding of bacillary dysentery, a disease responsible for more than 700,000 deaths annually. 🌐 More info: https://lnkd.in/dDrz99pa #AbarcaPrize2024 #microbiology #researcher

🔬 In a phase 3 trial, lenacapavir twice a year for HIV prevention in cisgender women outperformed daily F/TAF and F/TDF in prevention. Lenacapavir efficacy was significantly superior compared to background HIV incidence and F/TDF, while F/TAF efficacy was comparable to background levels. 🔎 More information at: https://ow.ly/11WZ50SQVTb #HIV #prevention #medicaladvances #research

Un estudio del IRB Barcelona y el Hospital Sant Joan de Déu Barcelona ha desarrollado modelos de Drosophila para investigar el sarcoma de Ewing, superando la toxicidad extrema del oncogén EWS-FLI. Publicado en Open Biology, este avance permite replicar las vías oncogénicas en moscas genéticamente modificadas, facilitando el estudio de esta agresiva neoplasia que afecta principalmente a adolescentes y jóvenes. 📚 Más información en Gaceta Médica: https://ow.ly/U0C350SRUom Serena Mahnoor #sarcomadeewing #estudio #investigación #drosophila

La vacuna Shingrix (GSK) contra el herpes zóster podría desacelerar hasta 9 meses la demencia, según un estudio de la University of Oxford publicado en la revista Nature. La investigación, que involucró a más de 200.000 personas, muestra que Shingrix reduce el riesgo de demencia en un 17% comparado con la vacuna Zostavax y en un 23-27% respecto a otras vacunas. Aunque los resultados son prometedores, los expertos señalan la necesidad de continuar investigando antes de recomendar la vacuna Shingrix para prevenir la demencia. 🔎 Más información vía Gaceta Médica: https://lnkd.in/dXXk3mME 👨🏻💼 Paul Harrison, profesor de Psiquiatría y responsable del estudio en Oxford Health Biomedical Research Centre (OH BRC). #demencia #investigaciónmédica #vacunas #herpeszóster

3D-printed blood vessels mimicking human veins could enhance heart bypass outcomes. These flexible, gel-like tubes might replace current veins used in surgery, improving treatment for cardiovascular diseases. 📚 More information at: https://lnkd.in/eTYD4FZh 🌐 The University of Edinburgh Heriot-Watt University Norbert Radacsi Faraz Fazal #medicalresearch #medicaladvances #cardiovascular #bypass

👏 Breakthrough in hearing restoration! 🔬 Researchers have used CRISPR-Cas9 to correct mutations in the microRNA MIR96, linked to autosomal dominant deafness 50 (DFNA50). Using adeno-associated viruses, they were able to improve hearing and hair cell survival in affected mice, creating a potential treatment for this form of inherited hearing loss. 🔎 More information at: https://lnkd.in/gyE4hvyB #medicaladvances #science #researchers #treatment #hearingloss

🧠 A review in Alzheimer's & Dementia highlights that sex and gender influence Alzheimer's resistance and resilience. Women with mild cognitive impairment show greater deterioration and faster progression to dementia than men. Factors such as the APOE ε4 allele, hormonal biology, and educational level also affect these differences. The researchers emphasize the need for sex- and gender-specific approaches to better understand and prevent cognitive decline in Alzheimer's disease. 📚 More information at: https://lnkd.in/dUvmRWQh #Medicaladvances #Science #Alzheimer #Dementia

💉 La FDA ha aprobado la V116, una vacuna antineumocócica 21-valente de MSD para adultos. Cubre los serotipos responsables del 84% de la enfermedad neumocócica invasiva en mayores de 50 años, incluyendo ocho serotipos no cubiertos por otras vacunas antineumocócicas ya aprobadas. V116 ha mostrado respuestas inmunitarias sólidas en estudios de fase 3. Se espera que el Comité Asesor de los CDC haga pronto recomendaciones sobre su uso, y la vacuna está en revisión por la Agencia Europea de Medicamentos. 🔎 Más información en: https://lnkd.in/dQie_5Bs #medicaladvances #science #investigación #vacuna